New nasal spray could shorten sinusitis suffering
NCT ID NCT06264141
First seen Apr 23, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tested a nitric oxide nasal spray (NONS) against a plain saline spray for treating recurrent acute sinusitis. 162 adults started the spray at the first sign of a new sinus infection. The goal was to see if NONS could speed up symptom relief and reduce the need for other medications like steroids or antibiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE RHINOSINUSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alpha Recherche Clinique LeBourneuf
Québec, Quebec, G2J 0C4, Canada
-
Alpha Recherche Clinique Val-Belair
Québec, Quebec, G3K 2P8, Canada
-
Cliantha Research
Mississauga, Ontario, L4W 1V7, Canada
-
Clinical Research of Ontario
Scarborough Village, Ontario, M1S 4T7, Canada
-
Intermed Groupe Santé
Chicoutimi, Quebec, G7H 7Y8, Canada
-
Okanegan Clinical Trials
Kelowna, British Columbia, V1Y 1Z9, Canada
-
Richmond Clinical Trials (Okanagan Clinical Trials Satelite Site)
Richmond, British Columbia, V6V 2L1, Canada
Conditions
Explore the condition pages connected to this study.